Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) shares were up 3.5% on Monday . The stock traded as high as $4.83 and last traded at $4.79. Approximately 41,010 shares traded hands during mid-day trading, an increase of 36% from the average daily volume of 30,073 shares. The stock had previously closed at $4.63.
Ono Pharmaceutical Trading Up 0.8%
The firm’s fifty day moving average price is $4.89 and its two-hundred day moving average price is $4.95.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Read More
- Five stocks we like better than Ono Pharmaceutical
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
